Intrinsic Value

The intrinsic value of PZ Cormay SA (CRM) under the Base Case is PLN per share. Compared with the current market price of 0.469 PLN, the stock appears .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

CRM Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when CRM is below its intrinsic value
Today Hidden ·
CRM Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to CRM

Fundamental Analysis

What PZ Cormay Does

Health Care

PZ Cormay SA makes in vitro diagnostic products used by laboratories and hospitals to test blood and other biological samples. Its core business is selling reagents, analyzers, and related consumables that help medical labs run routine chemistry, hematology, and other diagnostic tests. The company also earns money from service, maintenance, and recurring reagent sales tied to its installed testing equipment.

Headquarters
Poland PL
Employees
218
IPO date
Aug 20, 2008
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue CRM Research

Decided on PZ Cormay? Get an email when CRM reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one CRM stock?

The intrinsic value for PZ Cormay SA (CRM) under the Base Case is PLN.

Is CRM stock undervalued or overvalued?

Compared with the current market price of 0.469 PLN, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top